Review of ADHD pharmacotherapies: Advantages, disadvantages, and clinical pearls

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 48, Issue 3, 2009, Pages 240-248

  Daughton, Joan M ^a,b   Kratochvil, Christopher J ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; CLONIDINE; DEXAMPHETAMINE; DEXEDRINE SPANSULE; DEXMETHYLPHENIDATE; FLUOXETINE; GUANFACINE; LISDEXAMFETAMINE; METHYLPHENIDATE; MODAFINIL; PAROXETINE; UNCLASSIFIED DRUG;

ANOREXIA; ATTENTION DEFICIT DISORDER; CARDIOTOXICITY; DECREASED APPETITE; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; HEADACHE; HUMAN; HYPOTENSION; INSOMNIA; IRRITABILITY; JAUNDICE; LIVER INJURY; PRIORITY JOURNAL; REVIEW; SEIZURE; SIDE EFFECT; SKIN ALLERGY; STEVENS JOHNSON SYNDROME; SUDDEN DEATH; SUICIDAL IDEATION; TIC; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 62849109902     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/CHI.0b013e318197748f     Document Type: Article

References (9)

1. Beiderman J, Spencer TJ. Psychopharmacological interventions. Child Adolesc Psychiatric Clin N Am. 2008;17:439-458.
2. American Academy of Pediatrics Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperactivity Disorder. Treatment of attention deficit/hyperactivity disorder: overview of die evidence. Pediatrics. 2005;115:e749-e757 (doi:10.1542/peds.2004-2560).
3. Pliskz S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:894-921.
4. Faraone SP, Biederman J, Morley Christopher P et al. Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47:994-1009.
5. Hinshaw SP. Moderators and mediators of treatment outcome for youth with ADHD: understanding for whom and how interventions work. J Pediatr Psychol. 2007;32:664-675.
6. Towbin K. Paying attention to stimulants: height, weight, and cardiovascular monitoring in clinical practice. J Am Acad Child Adolesc Psychiatry. 2008;47:977-980.
7. Red Book: Pharmacy's Fundamental Reference. 2008 ed. Montvale, NJ: Thomson Healthcare; 2008:203-804.
8. Faraone SV, Spencer TJ, Aleadri M et al. Comparing the Efficacy of Medications Used for ADHD Using Meta-Analysis. Paper Presented at the 156th Annual Meeting of the American Psychiatric Association. San Francisco: May 2003.
9. Pelham WE Jr, Greenslade KE, Vodde-Hamilton M et al. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methytphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics. 1990;86:226-237.